Seller record · Research vendor

Onyx Research

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician, physician or prescriber is named anywhere on the site. The only gate on entry is a self-asserted age of twenty one. 3 more criteria also fail; see the table below.

At a glance

Onyx ResearchResearch vendor

4/8criteria passed

Price: Printed on its own pages before sign-up
Sells: research peptides in vials, capsule research compounds
FDA letters: None on file

Visit Onyx Research See all eight dispositions

Research vendor. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A research peptide seller whose certificate library is the unusual part: a signed certificate per lot, tied to a lot number, and reachable without an account. It names no company anywhere on its own pages.

Operating entity No legal entity name appears on the about, contact, terms, privacy or research-use agreement pages, or in the site-wide footer. The only name printed anywhere, including the copyright line, is the brand.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	FAIL	Onyx Research's website
S2	Prescription gating	FAIL	Onyx Research's tesamorelin product page
S3	Pharmacy identification	FAIL	Onyx Research's terms and conditions
S4	Compounding disclosure	PASS	Onyx Research's terms and conditions
S5	Analytical documentation	PASS	Onyx Research's test results page
S6	Business address	FAIL	Onyx Research's contact page
S7	Price disclosure	PASS	Onyx Research's tesamorelin product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician, physician or prescriber is named anywhere on the site. The only gate on entry is a self-asserted age of twenty one.Source: Onyx Research's website.

S2FAILA product page carries a quantity selector and an add-to-cart button with no step in between, and the cart loads directly. Nothing beyond the age click-through stands between a visitor and an order.Source: Onyx Research's tesamorelin product page.

S3FAILNo pharmacy is named, and the terms say the opposite in the seller's own words: it is not a compounding pharmacy under 503A and not an outsourcing facility under 503B.Source: Onyx Research's terms and conditions.

S4PASSThe seller offers no compounded drug and says so. A footer notice on every page states that its products are not evaluated by the Food and Drug Administration and are for laboratory research use only.Source: Onyx Research's terms and conditions.

S5PASSThe test-results page lists a signed certificate per lot for every catalog item, each tied to a lot number. The certificates open as real documents, one of them a file of 288 kilobytes, rather than as a page about certificates.Source: Onyx Research's test results page.

S6FAILNo street address appears anywhere on the site. The contact page offers an email address and stated support hours and no postal address.Source: Onyx Research's contact page.

S7PASSPrices are printed on the shop grid and on every product page, reachable with no account, among them a tesamorelin vial at 85.50 dollars against a struck-through 95 dollars.Source: Onyx Research's tesamorelin product page.

S8PASSNo FDA warning letter names the storefront under any of its three spellings, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides in vials, capsule research compounds.

Visit Onyx Research

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.